Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
April 28, 2020 at 10:19 pm EDT
Share
Autobio Diagnostics Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 2,679.435 million compared to CNY 1,929.676 million a year ago. Operating income was CNY 894.239 million compared to CNY 653.940 million a year ago. Net income was CNY 774.163 million compared to CNY 562.570 million a year ago. Basic earnings per share from continuing operations was CNY 1.84 compared to CNY 1.34 a year ago.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
